Canada Markets closed


Dusseldorf - Dusseldorf Delayed Price. Currency in EUR
Add to watchlist
80.98-0.12 (-0.15%)
At close: 07:00PM CEST
Full screen
Previous Close81.10
Bid81.40 x 0
Ask81.68 x 0
Day's Range75.98 - 80.98
52 Week Range75.98 - 115.75
Avg. Volume0
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Zacks

    Here's Why Momentum in UCB SA (UCBJF) Should Keep going

    If you are looking for stocks that are well positioned to maintain their recent uptrend, UCB SA (UCBJF) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

  • Zacks

    What Makes UCB SA (UCBJF) a Good Fit for "Trend Investing"

    UCB SA (UCBJF) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

  • Reuters

    UPDATE 2-U.S. FDA approves UCB's drug for rare childhood epilepsy

    Belgian biotech firm UCB SA said on Monday the U.S. Food and Drug Administration (FDA) approved its drug to treat seizures associated with Lennox-Gastaut Syndrome (LGS), a rare form of childhood epilepsy. The drug, branded as Fintepla, already has the U.S. approval to treat another form of childhood-onset epilepsy, Davet Syndrome (DS), in patients aged two years and older.